SICHUAN KELUN-BIOTECH BIOPHARMACEUT financial statements, including revenue, expenses, profit, and loss
The total revenue of 6990 for the last semiannual is 533.97 M HKD, and it's 54.87% lower compared to the previous semiannual. The net income of H2 23 is -586.63 M HKD.